4-Methoxy-2-methylbenzoic acid

We are 4-Methoxy-2-methylbenzoic acid CAS:6245-57-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Methoxy-2-methylbenzoic acid
CAS.NO:6245-57-4
Synonyms:4-Methoxy-2-methylbenzoic acid
2-Methyl-p-anisic acid
2-methyl-4-methoxybenzoic acid
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 294.3±20.0 °C at 760 mmHg
Melting Point 177-181ºC(lit.)
Molecular Formula C9H10O3
Molecular Weight 166.174
Flash Point 118.6±15.3 °C
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.541
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

4-Methoxy-2-methylbenzoic acid


Related News: The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.benzo[b]naphtho[1,2-d]furan-10-boronic acid CAS:1256544-74-7 “Out of an abundance of caution and based on the latest advice from leading health experts, we’re closing all our corporate offices, stores and contact centers in mainland China through February 9.”isocianato de etilo CAS:109-90-0 From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.3,3'-Dibromo-1,1'-biphenyl From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.

Related Products
Product Name
6-Oxo-1,6-dihydro-3-pyridazinecarboxamide View Details
Ethyl 2-BOC-aminothiazole-5-carboxylate View Details
2-[3-(Dimethylamino)propionyl]thiophene Hydrochloride View Details
Polyquaternium-39 Cas:25136-75-8 manufacturer 6-Chloro-5-fluoroindolin-2-one manufacturer 1,1-Cyclohexanediacetic acid manufacturer CAS:562-90-3 Wacker ES 15 manufacturer 1-(benzotriazol-1-yl)octan-1-one manufacturer